DGAP-AFR: Vivoryon Therapeutics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

2020. augusztus 20., csütörtök, 07:00







DGAP Preliminary announcement financial reports: Vivoryon Therapeutics AG


/ Preliminary announcement on the disclosure of financial statements






Vivoryon Therapeutics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]








20.08.2020 / 07:00



Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Vivoryon Therapeutics AG hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report (half-year/Q2)


Language: German

Date of disclosure: August 27, 2020

Address: https://www.vivoryon.com/investors-news/financial-information/


Language: English

Date of disclosure: August 27, 2020

Address: https://www.vivoryon.com/investors-news/financial-information/














20.08.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de













Language: English
Company: Vivoryon Therapeutics AG

Weinbergweg 22

06120 Halle/Saale

Germany
Internet: www.vivoryon.com





 
End of News DGAP News Service





1110097  20.08.2020 



fncls.ssp?fn=show_t_gif&application_id=1110097&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum